Literature DB >> 26501223

Tricuspid Valve Surgery in Patients with Isolated Tricuspid Valve Endocarditis: Analysis of Perioperative Parameters and Long-Term Outcomes.

Bettina Pfannmueller1, Mareike Kahmann1, Piroze Davierwala1, Martin Misfeld1, Farhad Bakhtiary1, Christian Binner1, Christian Etz1, Friedrich Wilhelm Mohr1.   

Abstract

Background The aim of this study was to evaluate the perioperative characteristics and the short- and mid-term outcomes in patients undergoing tricuspid valve (TV) surgery for isolated TV endocarditis. Patients and Methods A total of 56 patients with isolated TV endocarditis underwent TV surgery at a single center between June 1995 and February 2012. Mean age of patients was 53.8 ± 17.1 years, 39 (69.6%) being male. The mean left ventricular ejection fraction was 60.4 ± 13.6% and 13 (23.2%) patients had diabetes mellitus. Average logistic EuroSCORE was 19.4 ± 17.0%. Mean follow-up was 4.7 ± 3.8 years. Results Microbiological investigations revealed positive blood cultures in 89.1% of patients and positive intraoperative swabs in 51.9%. The most common pathogen (42.9%) isolated was Staphylococcus aureus, followed by coagulase-negative staphylococcus (17.9%). Discussion A history of intravenous drug abuse (IVDA) was recorded in 11 patients (19.6%), of which 8 patients additionally had hepatitis C. A total of 15 patients (26.8%) had a permanent pacemaker/implantable cardioverter-defibrillator in situ. TV replacement was performed in 22 patients (39.3%) and TV repair was performed in 34 patients (60.7%). Overall 30-day mortality was 12.5%. Five-year survival was 63.9 ± 7.2% (95% confidence interval [CI]: 64.0-137.5 months). Freedom from reoperation for recurrent TV endocarditis was 91.7 ± 4.0% (95% CI: 152.3-179.3 months) at 5 years. Conclusion Blood culture is the most important tool to detect the causative pathogen causing IE of TV. The high risk of hepatitis C in patients with IVDA and IE of the TV should be mentioned. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 26501223     DOI: 10.1055/s-0035-1564926

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  6 in total

1.  Implications of Drug Use Disorders on Spine Surgery.

Authors:  Christopher S Ferari; Gennadiy A Katsevman; Patricia Dekeseredy; Cara L Sedney
Journal:  World Neurosurg       Date:  2020-01-08       Impact factor: 2.104

2.  Impact of Substance Use Disorder on Midterm Mortality After Valve Surgery for Endocarditis.

Authors:  Alysse G Wurcel; Griffin Boll; Deirdre Burke; Rani Khetarpal; Patrick J Warner; Alice M Tang; Kenneth G Warner
Journal:  Ann Thorac Surg       Date:  2019-10-17       Impact factor: 4.330

3.  Drug Use and Postoperative Mortality Following Valve Surgery for Infective Endocarditis: A Systematic Review and Meta-analysis.

Authors:  Ryan Hall; Michael Shaughnessy; Griffin Boll; Kenneth Warner; Helen W Boucher; Raveendhara R Bannuru; Alysse G Wurcel
Journal:  Clin Infect Dis       Date:  2019-09-13       Impact factor: 9.079

4.  Long term surgical outcomes for infective endocarditis in people who inject drugs: a systematic review and meta-analysis.

Authors:  David Goodman-Meza; Robert E Weiss; Sebastián Gamboa; Abel Gallegos; Alex A T Bui; Matthew B Goetz; Steven Shoptaw; Raphael J Landovitz
Journal:  BMC Infect Dis       Date:  2019-11-08       Impact factor: 3.090

5.  A 34-Year-Old Male Intravenous Drug User with a Third Episode of Tricuspid Valve Endocarditis Treated with Repeat Valve Surgery.

Authors:  Jeffrey W Cannon; J W Awori Hayanga; Thomas B Drvar; Matthew Ellison; Christopher Cook; Muhammad Salman; Harold Roberts; Vinay Badhwar; Heather K Hayanga
Journal:  Am J Case Rep       Date:  2021-03-29

6.  Characteristics and outcomes of patients with right-sided endocarditis undergoing cardiac surgery.

Authors:  Carolyn Weber; Asmae Gassa; Kaveh Eghbalzadeh; Julia Merkle; Ilija Djordjevic; Johanna Maier; Anton Sabashnikov; Antje-Christin Deppe; Elmar W Kuhn; Parwis B Rahmanian; Oliver J Liakopoulos; Thorsten Wahlers
Journal:  Ann Cardiothorac Surg       Date:  2019-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.